Pharmaceutical - tasquinimod

Filter

Current filters:

tasquinimod

Popular Filters

Milestone for Active Biotech in tasquinimod collaboration with Ipsen

22-05-2012

Sweden's Active Biotech (Nasdaq OMX Nordic: ACTI) has received a 10 million-euro ($127 million) milestone…

Active BiotechBiotechnologyFinancialIpsenOncologyPharmaceuticalResearchtasquinimod

Back to top